Pancreatic Cancer Research

ResearcherKobe UniversityActive in the last 2 years

Dongha Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6796-1891; OpenAlex author ID A5101888437. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2025: 3 papers · 2026: 5 papers

Papers 8

  1. Successful management of refractory chylous ascites using a Denver shunt following conversion surgery for unresectable locally advanced pancreatic cancer. Co-author DOI 10.1007/s12328-026-02376-3↗
  2. Intraoperative frozen section analysis of the portal or superior mesenteric vein transection margin in pancreatectomy with venous resection for pancreatic canc… Co-author DOI 10.1016/j.gassur.2026.102410↗
  3. Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer. Co-author DOI 10.1245/s10434-025-18491-3↗
  4. ASO Visual Abstract: Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer. Co-author DOI 10.1245/s10434-025-18718-3↗
  5. Delayed Initiation of S-1 Adjuvant Chemotherapy Impairs Survival in Patients With Curatively Resected Pancreatic Cancer. Co-author DOI 10.21873/anticanres.18004↗
  6. Prognostic Significance of GLIM-Defined Malnutrition in Patients With Resectable Pancreatic Adenocarcinoma Following Upfront Surgery. Co-author DOI 10.1002/ags3.70059↗
  7. Prognostic Impact of Unplanned Total Pancreatectomy in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis. Co-author DOI 10.1002/jhbp.12176↗
  8. Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: … Co-author DOI 10.1002/jhbp.12181↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroaki Yanagimoto · 5 shared papers, 2025–2026 · strength 1.27
  2. Jun Ishida · 5 shared papers, 2025–2026 · strength 1.27
  3. Takuya Mizumoto · 5 shared papers, 2025–2026 · strength 1.27
  4. Yoshihide Nanno · 5 shared papers, 2025–2026 · strength 1.27
  5. Takumi Fukumoto · 5 shared papers, 2025–2026 · strength 1.27
  6. Sadaki Asari · 5 shared papers, 2025–2026 · strength 1.27
  7. Hirochika Toyama · 4 shared papers, 2026 · strength 1.02
  8. Keiko Kamei · 2 shared papers, 2025–2026 · strength 0.53
  9. Ippei Matsumoto · 2 shared papers, 2025–2026 · strength 0.53
  10. Chihoko Nobori · 2 shared papers, 2025–2026 · strength 0.53
  11. Katsuya Ami · 1 shared paper, 2026 · strength 0.29
  12. Mamoru Takenaka · 1 shared paper, 2025 · strength 0.25
  13. Takeshi Sudo · 1 shared paper, 2025 · strength 0.16
  14. Hiroaki Nagano · 1 shared paper, 2025 · strength 0.16
  15. Kenichi Hakamada · 1 shared paper, 2025 · strength 0.16
  16. Sohei Satoi · 1 shared paper, 2025 · strength 0.16
  17. Masafumi Imamura · 1 shared paper, 2025 · strength 0.16
  18. Masaaki Hidaka · 1 shared paper, 2025 · strength 0.16
  19. Teijiro Hirashita · 1 shared paper, 2025 · strength 0.16
  20. Akihiko Horiguchi · 1 shared paper, 2025 · strength 0.16
  21. Shugo Mizuno · 1 shared paper, 2025 · strength 0.16
  22. Shuji Suzuki · 1 shared paper, 2025 · strength 0.16
  23. Naoto Gotohda · 1 shared paper, 2025 · strength 0.16
  24. Shigeru Marubashi · 1 shared paper, 2025 · strength 0.16
  25. Kohei Nakata · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.